Publications by authors named "Roger A'Hern"

Claim this Profile
P
Prospective randomised controlled trial to compare tissue reactions and scarring with polypropylene versus polyglactin 910 sutures in periocular skin.
Tessa Fayers, John S Vekinis, Laura Ah-Kye, David Parham, Priscilla Anketell, Roger A'Hern

Br J Ophthalmol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'I presumed the pain would eventually get better by itself'; challenges with access to rehabilitation for upper limb dysfunction after breast cancer treatment - Descriptive and qualitative findings from a cross-sectional survey.
Marie-Clare Johnson, Alison Hazel McGregor, Roger A'Hern, Daniel Richard Leff, Mary Wells

Eur J Surg Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employing multiple synchronous outcome samples per subject to improve study efficiency.
Roger P A'Hern

BMC Med Res Methodol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time imaging of single neuronal cell apoptosis in patients with glaucoma.
Maria F Cordeiro, Eduardo M Normando, M Jorge Cardoso, Serge Miodragovic, Seham Jeylani, Roger A'Hern

Brain· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?
Roger P A'Hern

J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy.
Navita Somaiah, Melvin L K Chua, Sara Bourne, Frances Daley, Roger A' Hern

Radiother Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Roger A'Hern

N Engl J Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039).
Alexandra Leary, Abigail Evans, Stephen R D Johnston, Roger A'Hern, Judith M Bliss

Clin Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma.
Beatrice Seddon, Michelle Scurr, Robin L Jones, Zoe Wood, Cerys Propert-Lewis, Roger A'Hern

Clin Sarcoma Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer.
Neill Patani, Anita K Dunbier, Helen Anderson, Zara Ghazoui, Ricardo Ribas, Roger A'hern

Clin Cancer Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance.
Charlotte K Y Ng, Britta Weigelt, Roger A'Hern, Francois-Clement Bidard, Christophe Lemetre

Cancer Res· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy.
Melvin Lee Kiang Chua, Simon Horn, Navita Somaiah, Sue Davies, Lone Gothard, Roger A'Hern

Radiat Environ Biophys· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy for breast cancer, the TARGIT-A trial.
Joanne S Haviland, Roger A'Hern, Soeren M Bentzen, Timothy Whelan, Judith M Bliss

Lancet· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
Rachael Natrajan, Paul M Wilkerson, Caterina Marchiò, Salvatore Piscuoglio, Charlotte K Y Ng, Roger A'hern

J Pathol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of age and HRT use with breast density as assessed by Quantra™.
Philippa Skippage, Louise Wilkinson, Steven Allen, Nicola Roche, Mitch Dowsett, Roger A'hern

Breast J· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taxane benefit in breast cancer--a role for grade and chromosomal stability.
Roger P A'Hern, Mariam Jamal-Hanjani, A Marcell Szász, Stephen R D Johnston, Jorge S Reis-Filho

Nat Rev Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance.
Anita K Dunbier, Zara Ghazoui, Helen Anderson, Janine Salter, Ashutosh Nerurkar, Roger A'hern

Clin Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer.
John M S Bartlett, Roger A'hern, Tammy Piper, Ian O Ellis, Mitch Dowsett

Breast Cancer Res Treat· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations.
Daniel Wetterskog, Paul M Wilkerson, Daniel N Rodrigues, Maryou B Lambros, Karen Fritchie, Roger A'Hern

Histopathology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer.
Ben P Haynes, Giuseppe Viale, Viviana Galimberti, Nicole Rotmensz, Bianca Gibelli, Roger A'Hern

Breast Cancer Res Treat· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to S. Pauwels et al.
Elizabeth J Folkerd, J Michael Dixon, Roger P A' Hern, Mitch Dowsett

J Clin Oncol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.
Paul Finnon, Sylwia Kabacik, Alan MacKay, Claudine Raffy, Roger A'Hern

Radiother Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo.
Lesley-Ann Martin, Sunil Pancholi, Ian Farmer, Stephanie Guest, Ricardo Ribas, Roger A'Hern

Breast Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer.
Elizabeth J Folkerd, J Michael Dixon, Lorna Renshaw, Roger P A'Hern, Mitch Dowsett

J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients.
Roberta Ferraldeschi, Monica Arnedos, Kristen D Hadfield, Roger A'Hern, Suzie Drury

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis